Clinical trial
Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors
NCT00186953 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00186953 |
|---|---|
| Title | Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors |
| Official title | Determination of Optimal Dose and Safety Profile of Optison Ultrasound Contrast Agent in Pediatric Solid Tumor Patients |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Abdominal Neoplasms, Pelvic Neoplasms |
| Intervention type | Drug |
| Interventions | Optison |
| Enrollment | 14 |
| Start date | Jun 1, 2002 |
| Primary completion | Aug 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 20, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: